Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
My name is Brandon Mitchell and I live in Calgary, Alberta
NAD precursors such as NMN and NR have human studies, but outcomes depend on context and study design
How to Read a BPC-157 or TB-500 Study Applying a few disciplined checks to any paper or product claim quickly separates signal from marketing: Identify the exact molecule
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Is KPV better than BPC-157 for gut inflammation
US$ 22.72
US$ 29.69
US$ 24.91
US$ 28.06